share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Taraporevala Cyrus

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Taraporevala Cyrus

辉瑞 | 4:持股变动声明-董事 Taraporevala Cyrus
美股sec公告 ·  07/01 19:29
Moomoo AI 已提取核心信息
Cyrus Taraporevala, a reporting person for Pfizer Inc [PFE], has engaged in a transaction involving the company's stock on June 27, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, have not been disclosed in the announcement. Investors are advised to await further information to fully understand the impact of this event on their investment decisions regarding Pfizer stock.
Cyrus Taraporevala, a reporting person for Pfizer Inc [PFE], has engaged in a transaction involving the company's stock on June 27, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, have not been disclosed in the announcement. Investors are advised to await further information to fully understand the impact of this event on their investment decisions regarding Pfizer stock.
辉瑞公司[PFE]的报告人Cyrus Taraporevala于2024年6月27日参与了一笔公司股票交易。公告没有透露交易的具体细节,包括交易类型、状态币、涉及的股份数量、股份的性质、交易价格和交易后的参股金融信息。投资者应等待进一步信息,以充分了解此事件对于其有效的投资决策可能产生的影响。
辉瑞公司[PFE]的报告人Cyrus Taraporevala于2024年6月27日参与了一笔公司股票交易。公告没有透露交易的具体细节,包括交易类型、状态币、涉及的股份数量、股份的性质、交易价格和交易后的参股金融信息。投资者应等待进一步信息,以充分了解此事件对于其有效的投资决策可能产生的影响。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息